Insider Trading Report for Eton Pharmaceuticals, Inc.

Opaleye Management Inc., a 10% owner of Eton Pharmaceuticals, Inc., reported several transactions involving the company's common stock between July 2nd and July 7th, 2026. These transactions primarily involved the disposal of shares. On July 2nd, 65,000 shares were sold at a weighted average price of $37.3851, and an additional 25,000 shares were sold at the same average price. On July 6th, 10,000 shares were sold at $38.00 per share. Further disposals occurred on July 7th, with 20,000 shares sold at a weighted average price of $38.3728, and 6,685 shares also sold at the same weighted average price. These sales were conducted through Opaleye, L.P. and a separately managed account, with Opaleye Management, Inc. disclaiming beneficial ownership beyond its pecuniary interest.